Organic Active Ingredients TRIZ Cases

Antisense oligonucleotides block aberrant splice sites in ABCA4 pre-mRNA, correcting transcripts to halt Stargardt disease progression.

Replacing cyanide with carbon-based leaving groups boosts HNO yield at neutral pH without toxic byproducts.

Novel compounds form a covalent adduct with the flavin ring of FAD to resolve metabolic stability and clearance issues.

A tert-butyl alcohol co-solvent system enables rapid reconstitution of dantrolene sodium formulations.

Administering a melatonin agonist treats sleep disorders in cardiac patients with superior cervical ganglion dysfunction without causing drug addiction.

D-psicose activates glucokinase by promoting its transfer from the nucleus to the cytoplasm, addressing uncontrolled blood glucose in type 2 diabetes.

Balanced histidine, lysine, and threonine ratios treat pervasive developmental disorders while maintaining patient compliance with normal diets.

Mutant photosynthetic bacteria synthesize lycogen to overcome low lycopene bioavailability and limited natural extraction yields.

Small molecule inhibitors bind anti-apoptotic Bcl-2 proteins to overcome chemotherapy resistance and restore treatment efficacy.

Oral and topical pyrimidine derivatives block JAK enzymes locally, reducing systemic immunosuppression while treating ulcerative colitis and dermatitis.

A 1:1 adduct of sickle hemoglobin binds a single aldehyde molecule to form a conformationally stable complex that inhibits the sickled configuration.

Segmenting the dosage form into adhesive, intermediate, and hydrophobic layers resolves short residence time and washout by saliva.

Ionic liquid additives reduce Amphotericin B nephrotoxicity while maintaining antifungal efficacy against drug-resistant Candida auris.

Targeted STING agonist delivery concentrates cytokines in tumors while preventing adverse systemic immune responses.

Combining squirrel fibroma virus with reovirus creates a pharmaceutical composition that selectively infects cancer cells while sparing normal human tissue.

Benzenesulfonamides selectively inhibit perforin activity, avoiding the broad biological effects of non-selective inhibitors.

ROCK-PDK1 inhibitors selectively suppress TNFα and interferon production to reduce inflammatory stress without causing significant side effects.

Thiol isomerase inhibitors block cytokine production and attenuate food allergy symptoms by regulating mast cell activation.

Administering TNF antagonists alongside CD3 antibodies prevents severe cytokine release syndrome in patients intolerant to standard IL-6 treatments.

Topical pyrimidine compounds inhibit JAK kinases locally, avoiding systemic immunosuppression while treating atopic dermatitis.

Combining Cannabis sativa extracts with Calendula officinalis eliminates synthetic cytotoxicity while treating atopic dermatitis.

Combining cholesterol-conjugated nucleic acids with chloroquine overcomes systemic barriers and enhances therapeutic efficacy in cancer treatment.

Engineered T cells with PDCD1 gene disruption overcome PD-1 inhibition to maintain effector function and persistence during adoptive transfer.

Lithium triethylborohydride reduces tetrahydropyrido-dioxazine precursors to form 1,3-diazo-4-oxa-bicyclic derivatives.

Synergistic omega-6 to omega-3 fatty acid blend enhances nutritional bioavailability through balanced composition.

1,5-diazacarbazole compounds inhibit checkpoint kinase 1 to address insufficient efficacy and specificity in existing cancer therapies.

A blend of high amylose starch, cross-linked hydroxypropylated amylopectin, and pre-gelatinized common starch controls active pharmaceutical ingredient release.

A nonionic triblock copolymer delivery system enhances bioavailability of low solubility active agents through solubilization and permeability mechanisms.

Anti-DR5 antibody targets death receptor 5 to kill cancer cells while avoiding normal cell toxicity caused by non-specific binding.

Fermented mare milk compositions strengthen the immature mammal immune system using defined bacterial strains to mitigate infections.

A bone delivery system uses a segmented covering to hold and release therapeutic agents at surgical sites.

Combining citicoline and nicotinamide in an aqueous solution overcomes low oral bioavailability, slowing retinal nerve fiber loss.

Segmented gut microbiota analysis predicts Clostridium difficile infection treatment response, avoiding prolonged ineffective antibiotic trials.

Segmenting racemic bupropion isolates the active (S)-enantiomer, reducing adverse effects while maintaining therapeutic coverage.

Pyrimidinyl tricyclic enone derivatives inhibit RORγ activity, reducing IL-17 overproduction and addressing inflammatory diseases.

A long-acting PTH compound normalizes bone turnover markers and stabilizes BMD Z-scores through intermittent dosing cycles.

Azetidine estrogen receptor modulators degrade ER-alpha to overcome treatment resistance in metastatic breast cancer.

Combines anti-c-Met antibodies with aminoheteroaryl compounds to inhibit tumor growth.

Combining a PDE1B selective inhibitor with a second compound modulates neuronal signaling pathways to treat psychiatric disorders.

Internally cross-linked p53 transactivation domain-based inhibitor peptides target HDM2 and HDMX to restore tumor suppressor activity.

Heterocyclic compounds modulate gamma secretase to reduce amyloid beta, addressing limited effectiveness of existing inhibitors.

Glucocorticoid receptor antagonists block cortisol signaling to reduce anxiety and withdrawal symptoms in addiction therapy.

Selective PDE9 inhibition elevates cGMP to improve cognitive function without metabolic side effects of antipsychotics.

Dual inhibitor compounds target c-fms and c-kit receptors to modulate receptor protein tyrosine kinase activity.

A citrate-containing priming solution fills the extracorporeal blood circuit to provide anticoagulation without heparin.

PEG-modified diphenhydramine reduces blood-brain barrier crossing, minimizing drowsiness while maintaining antihistaminic activity.

Bouvardin analogs inhibit ribosome activity to block cancer cell growth while reducing toxicity through structural modifications.

Fatostatin A inhibits sterol regulatory element-binding protein activation to reduce lipogenic gene transcription.

Replacing G-CSF with sildenafil citrate and AMD3100 reduces fatigue and nausea while increasing cell yield.

Lower alcohol extraction at 80°C isolates carotenoids, reducing solvent costs and improving purity for industrial food applications.

A small dog food composition with probiotics modulates amino acid absorption.

Ball milling oxidized regenerated cellulose into compacted powder particles with controlled aspect ratio and high tapped density.

Dehydrated chloroplasts synthesize adenosine triphosphate via photosynthesis, resolving water instability issues for stable energy supplementation.

Pimavanserin reduces impulse control disorder severity through selective 5-HT2A receptor modulation without impairing motor function.

Glycine-enriched food formulations enhance slow wave sleep while masking unpleasant flavors to improve bowel movement regularity.

Optimized procyanidin A2 and quercetin ratios enhance autophagy activity to resolve melanin production bottlenecks in skin whitening formulations.

A topical composition containing vitamins B1, B6, and B9 reduces neuropathic pain through localized delivery.

Self-assembled 3D nucleic acid nanostructures deliver drugs via passive targeting, overcoming liposome instability and peptide thermal limits.

A biodegradable polylactic acid and dimethyl sulphoxide composition solidifies in situ to form an intramuscular implant.

Isolating the (S)-pirlindole enantiomer improves neuropathic pain relief while minimizing adverse reactions compared to racemic mixtures.

Extraction of specific molecular weight fractions addresses fatty liver disease by lowering liver size and improving safety without adverse effects.

Adeno-associated virus delivers ELOVL2 protein to retinal cells, reversing methylation-related decline in visual function.

N-[1-cyano-2-(phenyl)ethyl]-2-azabicyclo[2.2.1]heptane-3-carboxamides inhibit Cathepsin C.

A hydrogel tablet with a chitosan-sodium alginate shell and calcium carbonate core slows rapid ethanol uptake through gel swelling.

Polysulfated polysaccharides treat bone marrow edema by restoring proteoglycan synthesis and inhibiting catabolic enzymes to address underlying pathophysiology.

Modified cellulose ether matrices control drug release by balancing structural integrity with prolonged dissolution duration.

A fibrin-based hydrogel patch undergoes liquid-to-gel phase transition to deliver therapeutic agents directly to the injury site.

Silver-coated gold nanostars enable sensitive nucleic acid detection via dynamic DNA hairpin conformational switching.

Targeting EMP2 reduces PMN influx into alveoli, mitigating lung inflammation while preserving host defense.

Sintered ferrous amino acid particles reduce cytopathic effects against porcine viruses by controlling particle size and molecular weight.

Phase transfer catalysis reduces reaction temperature and time while eliminating harmful solvents in rilpivirine production.

Merges trazodone and gabapentin into a single composition that achieves effective pain relief at sub-effective doses, reducing side effects.

Crystalline aluminum orthophosphate binder forms through in situ reaction of aluminum metaphosphate with alumina.

Monohydric alcohol addition resolves low breaking strength and thermal instability in stick-shaped lipid peptide gels.

A fungal composition combining tryptamines and Hericium extracts modulates immune responses to reduce inflammation.

Anti-Aβ protofibril antibodies target amyloid-beta peptides to prevent disease onset and convert amyloid-positive subjects to negative status.

Ganoderma lucidum polysaccharide GLP-3 mediates chemotherapy drugs, reducing tumor size while alleviating toxic side effects on normal human cells.

Sulfonylalkylcyclodextrins target heparan sulfate proteoglycans to irreversibly inhibit diverse viruses, resolving host toxicity and resistance issues.

Targeted oligonucleotides upregulate ATP2A2 to enhance calcium transport and treat cardiac diseases.

Benzethonium chloride prevents inactivation and crystallization of anionic UV filters while maintaining microbial stability.

Quinone-fused oxazepine compounds inhibit peroxiredoxins by inducing enzyme hyperoxidation, reversing therapy resistance in cancer cells.

Vitamin E derivatives in ionic lipid nanoparticles enhance acquired immunity while minimizing side effects.

Mono or disubstituted vitamin K2 derivatives protect ketone functionalities to enhance chemical stability.

Amorphous solid dispersions improve Remdesivir aqueous solubility and room temperature stability, eliminating cold-chain storage requirements.

Administering cyclobenzaprine or amitriptyline addresses ineffective SSRI treatments by reducing symptom severity within specific time windows.

Replacing isothiocyanate with a new reaction pathway eliminates column chromatography, raising total yield from 3.5% to 40%.

A wearable phototherapy apparatus uses specific light wavelengths to stimulate nerves and elevate copper peptides.

Cyclic acetal groups at positions one and eleven provide hydrolysis resistance against metabolizing enzymes while maintaining high ACAT2 inhibitory activity.